Pulished Date August, 2019
ID: 213
Share on
Share on

North America Antifungal Drugs Market Research Report – Segmented By Drug Type, Therapeutic Indications, Application, Country (US, Canada, Rest of the North America) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 – 2024

Pulished: August, 2019
ID: 213
Pages: 145

North America Antifungal Drugs Market Size & Growth (2019 - 2024)

As per the report published, the size of the Antifungal Drugs Market in North America is estimated at $4.97 billion in 2019 and projected to be growing with CAGR of 3.7% reaching $5.96 billion by 2024. In the following years, the market is poised to grow significantly with the rising global population.

Antifungal drugs are used commonly for curing fungal infections occurring due to, unclean, unhygienic and damp environments. Invasion of epithelial tissue by microscopic organisms leads to fungal infections. Systemic fungal infections are those caused due to indigestion or inhalation of spores, leading to fungal pneumonia and diseases like candidiasis, meningitis, mucormycosis, etc. are caused by opportunistic fungus. Although the majority of the fungal infections and diseases are commonly non-lethal, they are very uncomforting to the host and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms such as by inhibiting cell wall formation, cell membrane disruption, and cell division.

The major factors driving the market are rising awareness of fungal infections with more and more cases of antifungal infections all over the world, an increase in government and corporate funding in the industry. Further, the growing public-private partnership in the pharmaceutical industry and the mounting popularity of over-the-counter antifungal drugs to cure dermal infections are responsible for the growth of North America antifungal drugs market. Also, the rising population with weak immune systems because of cancer chemotherapy or acquired immunodeficiency syndrome, in whom the fungal infections occur more frequently than average, is driving the market in North America. Existing high penetration of conventional drugs used for the treatment of common fungal infections is restraining the market growth.

High drug costs are a challenge faced by the market. Increasing treatment effectiveness can help in overcoming it.

This research report segmented and sub-segmented into the following categories:

  • By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines and Others
  • By Therapeutic Indications: Aspergillosis, Dermatophytosis, Candidiasis and Others
  • By Application: Powders, Ointments, Drugs and Pastes
  • By Country: US, Canada and Rest of the North America

Geographically, North America has commanded the largest share of the global antifungal drugs market. The United States antifungal drugs market contributes to the major share of the North America antifungal drugs market due to the presence of the leading companies. Canada's antifungal drug market is expected to grow fastest in the North America region.

The major companies dominating the market are Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories to name few.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Echinocandins

                                5.1.2 Azoles

                                5.1.3 Polyenes

                                5.1.4 Allylamines

                                5.1.5 Others

                5.2 By Therapeutic Indications   

                                5.2.1 Aspergillosis

                                5.2.2 Dermatophytosis

                                5.2.3 Candidiasis

                                5.2.4 Others

                5.3 By Application           

                                5.3.1 Powders

                                5.3.2 Ointments

                                5.3.5 Drugs

                                5.3.4 Pastes

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 United States

                                6.3 Canada 

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Alternaria    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Pfizer            

                8.3 Novartis       

                8.4 Sanofi-Aventis          

                8.5 Merck & Co.               

                8.6 Asperqillus  

                8.7 Kramer Laboratories               

                8.8 Bayer Healthcare     

                8.9 Enzon Pharmaceuticals          

                8.10 Glaxosmithkline Gilead       

                8.11 Abbott Laboratories             

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Antifungal Drugs Market By Region, From 2019 - 2024(USD Million)
  2. North America Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  3. North America Echinocandins Market By Region, From 2019 - 2024(USD Million)
  4. North America Azoles Market By Region, From 2019 - 2024(USD Million)
  5. North America Polyenes Market By Region, From 2019 - 2024(USD Million)
  6. North America Allylamines Market By Region, From 2019 - 2024(USD Million)
  7. North America Other Drugs Market By Region, From 2019 - 2024(USD Million)
  8. North America Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  9. North America Aspergillosis Market By Region, From 2019 - 2024(USD Million)
  10. North America Dermatophytosis Market By Region, From 2019 - 2024(USD Million)
  11. North America Candidiasis Market By Region, From 2019 - 2024(USD Million)
  12. North America Other Therapeutic Indications Market By Region, From 2019 - 2024(USD Million)
  13. North America Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  14. North America Powders Market By Region, From 2019 - 2024(USD Million)
  15. North America Ointments Market By Region, From 2019 - 2024(USD Million)
  16. North America Drugs Market By Region, From 2019 - 2024(USD Million)
  17. North America Pastes Market By Region, From 2019 - 2024(USD Million)
  18. United States Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  19. United States Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  20. United States Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  21. Canada Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  22. Canada Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  23. Canada Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample